Reports
Sale
Global Clinical Trials Market Size, Share, Trends, Forecast: By Design: Treatment Studies, Observational Studies; By Phase; By Service Type: Site Identification, Patient Recruitment, Laboratory Services, Analytical Testing Services, Others; By Therapy Area; By Application; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032
Global Clinical Trials Market Outlook
The clinical trials market size attained a value of USD 49.22 billion in 2023. The market is anticipated to grow at a CAGR of 5.4% during the forecast period of 2024-2032 to attain a value of nearly USD 79.02 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Demand for Oncology to Augment the Clinical Trials Industry Growth
Oncology clinical trials are more complex than other therapeutic disciplines since they require advanced treatments for specific malignancies. An oncology trial looks not only into the efficacy and safety of an antibiotic against infection, but also how it can improve the subject's quality of life. Because cancer research is growing at a quick rate, immunotherapy has shifted away from chemotherapy procedures and toward molecularly targeted medicines. The evolution of oncology clinical trials has seen rapid development in available clinical data, as well as a strong and rising pipeline of therapeutic candidates.
North America to Provide Significant Growth Opportunities to the Clinical Trial Industry
Geographically, North America accounts for a dominant share in the industry owing to large investment for outsourcing the big R&D companies. This is mainly due to the major demand for investments in drug development. Due to the rising COVID-19 cases, many big R&D firms have collaborated with government and non-government organisations to manufacture therapeutic drug injections. The United States is one of the largest global manufacturers of clinical trials as they are investing more in R&D development. Meanwhile, the Asia Pacific is expected to witness a robust growth in the forecast period due to the increasing focus of manufacturers to produce vaccines to decrease death risk due to the COVID-19 pandemic.
Clinical Trials: Market Segmentation
Clinical trials are research studies that are used to assess the effectiveness of a medicinal, surgical, or behavioural intervention. They are the primary method by which scientists determine whether a new treatment, such as a new medicine, diet, or medical instrument, is safe and effective in humans. A clinical trial is frequently performed to determine whether a new medication is more effective and has fewer negative side effects.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By design, the market is divided into:
- Treatment Studies
- Randomised Control Trial
- Adaptive Clinical Trail
- Non- Randomised Control Trial
- Observational Studies
- Cohort Studies
- Case Control Study
- Cross Section Study
- Ecological Study
- Others
The regional markets for clinical trials include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Focus on Therapeutic Drugs Generation to Bolster the Growth of Clinical Trials Industry
The global clinical trial industry is being driven by the increasing demand for the production of therapeutic drugs across the globe. Due to the COVID-19 pandemic, significant changes in the clinical trials industry has shifted the central point of many research and commercial companies to give attention on the development of new therapeutic drugs and vaccines for COVID-19. The industry is also predicted to develop as a result of government initiatives in emerging nations to promote medication discovery and constant technical advances. Over the forecast period, it can be expected that Phase III will grow and become significant as it is one of the most important stages in determining whether or not a new intervention is effective and useful for clinical purposes.
Key Industry Players in the Global Clinical Trials Market
The report presents a detailed analysis of the following key players in the global clinical trials market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- IQVIA
- Parexel International Corporation
- Charles River laboratory
- ICON Plc
- Syneos Health
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Design |
|
| Breakup by Phase |
|
| Breakup by Service Type |
|
| Breakup by Therapy Area |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Trial Market Overview
3.1 Global Clinical Trial Market Historical Value (2017-2023)
3.2 Global Clinical Trial Market Forecast Value (2024-2032)
4 Global Clinical Trial Market Landscape
4.1 Global Clinical Trial Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Clinical Trial Product Landscape
4.2.1 Analysis by Service Type
4.2.2 Analysis by Design
4.2.3 Analysis by Therapy Area
5 Global Clinical Trial Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Clinical Trial Market Segmentation
6.1 Global Clinical Trial Market by Design
6.1.1 Market Overview
6.1.2 Treatment Studies
6.1.2.1 Randomised Control Trial
6.1.2.2 Adaptive Clinical Trail
6.1.2.3 Non- Randomised Control Trial
6.1.3 Observational Studies
6.1.3.1 Cohort Studies
6.1.3.2 Case Control Studies
6.1.3.3 Cross Section Study
6.1.3.4 Ecological Study
6.1.3.5 Others
6.2 Global Clinical Trial Market by Phase
6.2.1 Market Overview
6.2.2 Phase I
6.2.3 Phase II
6.2.4 Phase III
6.2.5 Phase IV
6.3 Global Clinical Trial Market by Service Type
6.3.1 Market Overview
6.3.2 Site Identification
6.3.3 Patient Recruitment
6.3.4 Laboratory Services
6.3.5 Analytical Testing Services
6.3.6 Bio-Analytical Testing Services
6.3.6.1 Cell Based Assay
6.3.6.2 Virology Testing
6.3.6.3 PK/PD Testing Services
6.3.6.4 Method Development, Optimization, Validation
6.3.6.5 Serology, Immunogenicity & Neutralizing Antibodies
6.3.6.6 Bio Marker Testing Service
6.3.6.7 Other Bioanalytical Testing Services
6.3.7 Clinical Trial Data Management Services
6.3.8 Clinical Trial Supply and Logistic Services
6.3.9 Medical Device Testing Services
6.3.10 Other Clinical Trial Services
6.4 Global Clinical Trial Market by Therapy Area
6.4.1 Market Overview
6.4.2 Oncology
6.4.3 Infectious Disease
6.4.4 Neurology
6.4.5 Immunology
6.4.6 Cardiology
6.4.7 Genetic Disease
6.4.8 Women’s Health
6.4.9 Other Therapy Areas
6.5 Global Clinical Trial Market by Application
6.5.1 Market Overview
6.5.2 Small Molecule
6.5.3 Vaccine
6.5.4 Cell & Gene Therapy
6.5.5 Other Applications
6.6 Global Clinical Trial Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Clinical Trial Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Clinical Trial Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Clinical Trial Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Clinical Trial Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Clinical Trial Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 IQVIA
17.1.1 Financial Analysis
17.1.2 Service Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 PAREXEL International Corporation
17.2.1 Financial Analysis
17.2.2 Service Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Charles River Laboratory
17.3.1 Financial Analysis
17.3.2 Service Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 ICON Plc
17.4.1 Financial Analysis
17.4.2 Service Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Syneos Health
17.5.1 Financial Analysis
17.5.2 Service Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Labcorp Drug Development (COVANCE)
17.6.1 Financial Analysis
17.6.2 Service Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Wuxi Apptec
17.7.1 Financial Analysis
17.7.2 Service Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Charles River Laboratories
17.8.1 Financial Analysis
17.8.2 Service Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 PPD Inc
17.9.1 Financial Analysis
17.9.2 Service Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 ICON Plc
17.10.1 Financial Analysis
17.10.2 Service Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Medpace Holdings Inc
17.11.1 Financial Analysis
17.11.2 Service Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Acm Global Laboratories
17.12.1 Financial Analysis
17.12.2 Service Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Advanced Clinical
17.13.1 Financial Analysis
17.13.2 Service Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 SGS
17.14.1 Financial Analysis
17.14.2 Service Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 PSI CRO AG
17.15.1 Financial Analysis
17.15.2 Service Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Bio Agile Therapeutics
17.16.1 Financial Analysis
17.16.2 Service Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Clinical Trial Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The global clinical trial Market was valued at USD 49.22 billion in 2023.
The market is expected to grow at a CAGR of 5.4% from 2024 to 2032 to reach a value of USD 79.02 billion by 2032.
The industry is primarily being driven by the growing rates of R&D projects for the development of therapeutic drugs, development in technologies, increasing focus of manufacturers to produce vaccines to decrease death risk due to the COVID-19 pandemic, and increasing cancer research.
The key trends driving the market’s expansion are the increasing demand for the production of therapeutic drugs and increasing government initiatives.
The major regions in the industry are North America, Latin America, Europe, Middle East and Africa, and the Asia Pacific with North America accounting for the largest share in the market.
By design, the market is divided into treatment studies and observational studies. Treatment studies are further divided into randomised control trial, adaptive clinical trail and non- andomized control trial while observational studies are segmented into cohort studies, case control study, cross section study, and ecological study, among others.
The major players in the industry are IQVIA, PAREXEL International Corporation, Charles River Laboratory, ICON Plc, and Syneos Health, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER